Organization | Azienda Ospedaliera S. Maria della Misericordia

Azienda Ospedaliera S. Maria della Misericordia Report issue

Academic/Hospital Phase 2

Founded: Udine Italy (1775)

Organization Overview

First Clinical Trial

2009

NCT01008982

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2014

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 2 Trials (7)

belimumab (benlysta) (1 trial)

cisplatin (platinol) (1 trial)

docetaxel (taxotere) (1 trial)

gefitinib (iressa) (1 trial)

gemcitabine (gemzar) (1 trial)

pemetrexed (alimta) (1 trial)

vinorelbine (navelbine) (1 trial)

Drugs in Other Trials (3)

neostigmine (bloxiverz) (1 trial)

sugammadex (bridion) (1 trial)

triptorelin (Trelstar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Lung Neoplasms (Phase 2)

Sjogren's Syndrome (Phase 2)

Syndrome (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 4
# of Trial APIs: 10